PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19148552-6	2009	SP600125, a specific inhibitor of SAPK/JNK, reduced the amplification by tacrolimus of the FGF-2-induced VEGF release.	pyrazolanthrone	0-8	fibroblast growth factor 2	Mus musculus	91-96	
18932216-5	2009	Activations of ERKs and JNKs were detected in PDGF- and FGF-2-treated NIH3T3 cells, and the telomerase activities induced by PDGF and FGF were respectively inhibited by the addition of the ERK inhibitor, PD98059, and the JNK inhibitor, SP600125.	pyrazolanthrone	236-244	fibroblast growth factor 2	Mus musculus	56-61	
17181399-13	2007	SP600125, a specific inhibitor of SAPK/JNK, suppressed the amplification by rapamycin of the FGF-2-stimulated VEGF release similar to the levels of FGF-2 with SP600125.	pyrazolanthrone	0-8	fibroblast growth factor 2	Mus musculus	93-98	
18600399-7	2008	The amplification by PDGF-BB of FGF-2-stimulated VEGF release was reduced by PD98059, a specific inhibitor of MEK, or SP600125, a specific inhibitor of SAPK/JNK.	pyrazolanthrone	118-126	fibroblast growth factor 2	Mus musculus	32-37	
12697041-4	2003	SP600125, an inhibitor of SAPK/JNK, markedly reduced the FGF-2-induced VEGF release.	pyrazolanthrone	0-8	fibroblast growth factor 2	Mus musculus	57-62	
12697041-5	2003	SP600125 suppressed the FGF-2-induced phosphorylation of SAPK/JNK without affecting the phosphorylation of p44/p42 MAP kinase or p38 MAP kinase induced by FGF-2.	pyrazolanthrone	0-8	fibroblast growth factor 2	Mus musculus	24-29	
12697041-7	2003	A combination of SP600125 and SB203580 suppressed the FGF-2-stimulated VEGF release in an additive manner.	pyrazolanthrone	17-25	fibroblast growth factor 2	Mus musculus	54-59